» Authors » Fernando Pardo

Fernando Pardo

Explore the profile of Fernando Pardo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 908
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aliseda D, Marti-Cruchaga P, Zozaya G, Blanco N, Ponz M, Chopitea A, et al.
BJS Open . 2024 Sep; 8(5). PMID: 39329454
Background: Neoadjuvant treatment has shown promising results in patients with borderline resectable pancreatic ductal adenocarcinoma. The potential benefits of neoadjuvant treatment on long-term overall survival in patients with resectable pancreatic...
2.
Uriarte I, Santamaria E, Lopez-Pascual A, Monte M, Argemi J, Latasa M, et al.
Biochim Biophys Acta Mol Basis Dis . 2024 Apr; 1870(5):167166. PMID: 38642480
Background And Aims: Liver regeneration is essential for the preservation of homeostasis and survival. Bile acids (BAs)-mediated signaling is necessary for liver regeneration, but BAs levels need to be carefully...
3.
Blanco-Fernandez G, Serradilla-Martin M, Rotellar F, Latorre R, Jaen-Torrejimeno I, Munoz-Forner E, et al.
J Gastrointest Surg . 2024 Apr; 28(4):467-473. PMID: 38583897
Background: The effect of radiologic splenic vessels involvement (RSVI) on the survival of patients with pancreatic adenocarcinoma (PAC) located in the body and tail of the pancreas is controversial, and...
4.
Villodre C, Del Rio-Martin J, Blanco-Fernandez G, Cantalejo-Diaz M, Pardo F, Carbonell S, et al.
Surgery . 2023 Dec; 175(4):1134-1139. PMID: 38071134
Background: Textbook outcome is an interesting quality metrics tool. Information on textbook outcomes in distal pancreatectomy is very scarce. In this study we determined textbook outcome in a distal pancreatectomy...
5.
Carmona-Rodriguez L, Gajadhar A, Blazquez-Garcia I, Guerrero L, Fernandez-Rojo M, Uriarte I, et al.
Biofactors . 2023 May; 49(4):912-927. PMID: 37171157
The liver is the only solid organ capable of regenerating itself to regain 100% of its mass and function after liver injury and/or partial hepatectomy (PH). This exceptional property represents...
6.
Vilalta-Lacarra A, Aldaz A, Sala-Elarre P, Urrizola A, Chopitea A, Arbea L, et al.
Pancreatology . 2023 May; 23(4):411-419. PMID: 37169668
Background: Despite a potentially curative treatment, the prognosis after upfront surgery and adjuvant chemotherapy for patients with resectable pancreatic ductal adenocarcinoma (PDAC) is poor. Modified FOLFIRINOX (mFOLFIRINOX) is a cornerstone...
7.
Zozaya G, Cienfuegos J, Marti-Cruchaga P, Hernandez-Lizoain J, Baixauli J, Pardo F, et al.
Clin Transl Oncol . 2023 Apr; 25(8):2523-2531. PMID: 37027061
Purpose: To analyze the prognostic value of variables of the primary tumor in patients with synchronous liver metastases in colorectal cancer (CLRMs) treated with neoadjuvant chemotherapy and surgery. Methods/patients: From...
8.
Aliseda D, Marti-Cruchaga P, Zozaya G, Rodriguez-Fraile M, Bilbao J, Benito-Boillos A, et al.
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765691
Methods: Patients diagnosed with HCC and ICC treated by RE with further liver resection (LR) or LT between 2005-2020 were included. All patients selected were discarded for the upfront surgical...
9.
Cienfuegos J, Marti-Cruchaga P, Zozaya G, Hernandez Lizoain J, Martinez Regueira F, Pardo F, et al.
Rev Esp Enferm Dig . 2022 Nov; 115(8):428-434. PMID: 36412484
Background: although neoadjuvant chemoradiotherapy (NCRT) and surgery are accepted as treatments for pancreatic ductal adenocarcinoma (PDAC), some authors have highlighted the risks of delaying surgery. The objective of this study...
10.